1. Home
  2. CTMX vs KRUS Comparison

CTMX vs KRUS Comparison

Compare CTMX & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.04

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Logo Kura Sushi USA Inc.

KRUS

Kura Sushi USA Inc.

HOLD

Current Price

$53.90

Market Cap

650.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
KRUS
Founded
2008
2008
Country
United States
United States
Employees
N/A
3900
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
977.1M
650.6M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
CTMX
KRUS
Price
$4.04
$53.90
Analyst Decision
Strong Buy
Buy
Analyst Count
10
9
Target Price
$12.10
$81.11
AVG Volume (30 Days)
3.9M
406.1K
Earning Date
05-08-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.75
EPS
N/A
N/A
Revenue
$76,201,000.00
$282,763,000.00
Revenue This Year
N/A
$20.50
Revenue Next Year
$7.61
$20.68
P/E Ratio
$22.58
N/A
Revenue Growth
N/A
18.88
52 Week Low
$0.72
$42.62
52 Week High
$8.21
$95.98

Technical Indicators

Market Signals
Indicator
CTMX
KRUS
Relative Strength Index (RSI) 37.90 38.25
Support Level $4.02 $53.72
Resistance Level $4.72 $55.50
Average True Range (ATR) 0.27 3.82
MACD -0.04 -0.61
Stochastic Oscillator 3.70 7.85

Price Performance

Historical Comparison
CTMX
KRUS

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.

Share on Social Networks: